Lynparza 100 MG tablet UU 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FT6DW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,493
Award facts
- Contract value 100% obligated
- $24,493.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $24,493.22 to AmerSourceBergen Drug Corp for the supply of LYNPARZA 100 mg tablets (120 count) on January 30, 2026, with completion scheduled for February 23, 2026. This non-set-aside delivery order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., serves as a critical pharmaceutical distributor supporting federal medical procurement needs across military and veteran healthcare systems. The company operates under a significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which provides the overarching contract vehicle for this and similar pharmaceutical supply deliveries.
This delivery order represents a task order under the DLA Troop Support Medical comprehensive pharmaceutical supply program, which supports military treatment facilities and federal healthcare systems globally. LYNPARZA (olaparib) is a specialty oncology medication used in cancer treatment, consistent with AmerSourceBergen's demonstrated portfolio of delivering brand-name and generic medications across multiple therapeutic domains to federal health agencies. The competitive award to an established federal contractor with extensive experience fulfilling pharmaceutical requirements for the Defense Health Agency and other government healthcare systems demonstrates the company's capability to meet stringent federal procurement standards for essential medical commodities.
Quick answers
Who was awarded contract SPE2DR26FT6DW?
SPE2DR26FT6DW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FT6DW worth?
The government has obligated $24,493 on SPE2DR26FT6DW.
Is contract SPE2DR26FT6DW an order under another contract?
Yes. SPE2DR26FT6DW is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT6DW competed?
The extent of competition for SPE2DR26FT6DW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award